Abstract

Pediatric pharmacogenomics is a burgeoning field with the potential to transform pediatric medicine by unlocking personalized treatment approaches for children. This abstract delves into the significance of pediatric pharmacogenomics, elucidating its applications, challenges, and implications for personalized medicine in pediatric care. Genetic variations significantly influence medication response in children, necessitating tailored treatment strategies based on individual genetic profiles. From oncology to psychiatry and neonatal care, pediatric pharmacogenomics offers promising applications across various medical specialties, optimizing treatment outcomes and minimizing adverse effects. However, challenges such as limited data, ethical considerations, and integration into clinical practice must be addressed to realize its full potential. Despite these hurdles, pediatric pharmacogenomics represents a paradigm shift in pediatric medicine, paving the way for enhanced personalized care and improved outcomes for children worldwide.